PF-06940434

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06940434, covering 2025-05-28 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]